SMAD4 mutations found in unselected HHT patients
- 29 March 2006
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 43 (10), 793-797
- https://doi.org/10.1136/jmg.2006.041517
Abstract
Background: Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disease exhibiting multifocal vascular telangiectases and arteriovenous malformations. The majority of cases are caused by mutations in either the endoglin (ENG) or activin receptor-like kinase 1 (ALK1, ACVRL1) genes; both members of the transforming growth factor (TGF)-β pathway. Mutations in SMAD4, another TGF-β pathway member, are seen in patients with the combined syndrome of juvenile polyposis (JP) and HHT (JP-HHT). Methods: We sought to determine if HHT patients without any apparent history of JP, who were undergoing routine diagnostic testing, would have mutations in SMAD4. We tested 30 unrelated HHT patients, all of whom had been referred for DNA based testing for HHT and were found to be negative for mutations in ENG and ALK1. Results: Three of these people harboured mutations in SMAD4, a rate of 10% (3/30). The SMAD4 mutations were similar to those found in other patients with the JP-HHT syndrome. Conclusions: The identification of SMAD4 mutations in HHT patients without prior diagnosis of JP has significant and immediate clinical implications, as these people are likely to be at risk of having JP-HHT with the associated increased risk of gastrointestinal cancer. We propose that routine DNA based testing for HHT should include SMAD4 for samples in which mutations in neither ENG nor ALK1 are identified. HHT patients with SMAD4 mutations should be screened for colonic and gastric polyps associated with JP.Keywords
This publication has 36 references indexed in Scilit:
- Vascular abnormalities in the fingers of patients affected with hereditary hemorrhagic telangiectasia (HHT) as assessed by color doppler sonographyAmerican Journal of Medical Genetics Part A, 2005
- Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasiaHuman Mutation, 2005
- Hepatic manifestation is associated withALK1 in hereditary hemorrhagic telangiectasia: Identification of five novelALK1 and one novelENG mutationsHuman Mutation, 2005
- TGF-? receptor function in the endotheliumCardiovascular Research, 2005
- Transforming Growth Factor-β Receptor Mutations and Pulmonary Arterial Hypertension in ChildhoodCirculation, 2005
- Genetic conditions associated with intestinal juvenile polypsSeminars in Medical Genetics, Part C of the American Journal of Medical Genetics, 2004
- The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutationsJournal of Medical Genetics, 2004
- Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2Nature Genetics, 1996
- Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1Nature Genetics, 1994
- Juvenile polyposis–a precancerous conditionHistopathology, 1988